This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| UK 100 Leaders | Close (p) | Chg (p) | % Chg | % YTD |
| Randgold Resources Ltd | 4931 | 43.0 | 0.9 | 12.6 |
| Tesco PLC | 204.1 | -5.2 | -2.5 | 8.0 |
| Fresnillo PLC | 816 | -8.5 | -1.0 | 6.5 |
| Intertek Group PLC | 2459 | 29.0 | 1.2 | 5.4 |
| Imperial Tobacco Group PLC | 2934 | -16.0 | -0.5 | 3.5 |
| Shire PLC | 4741 | 55.0 | 1.2 | 4.6 |
| Johnson Matthey PLC | 3506 | 50.0 | 1.5 | 3.2 |
| Carnival PLC | 3016 | -32.0 | -1.1 | 3.3 |
| UK 100 Laggards | Close (p) | Chg (p) | % Chg | % YTD |
| Taylor Wimpey PLC | 125.7 | -7.1 | -5.4 | -8.8 |
| Persimmon PLC | 1459 | -80.0 | -5.2 | -7.5 |
| Tullow Oil PLC | 387 | -6.9 | -1.8 | -6.5 |
| Barratt Developments PLC | 431.4 | -23.3 | -5.1 | -8.4 |
| Weir Group PLC | 1767 | -10.0 | -0.6 | -4.5 |
| Marks & Spencer Group PLC | 448 | 1.1 | 0.3 | -6.4 |
| Hargreaves Lansdown PLC | 947.5 | -30.0 | -3.1 | -6.4 |
| Royal Bank of Scotland Group (The) PLC | 367.7 | -10.0 | -2.7 | -6.8 |
| Major World Indices | Mid/Close | Chg | % Chg | % YTD |
| UK UK 100 | 6,501.1 | -68.8 | -1.05 | -1.0 |
| UK | 16,011.0 | -74.5 | -0.46 | -0.5 |
| FR CAC 40 | 4,179.1 | -81.1 | -1.90 | -2.2 |
| DE DAX 30 | 9,648.5 | -189.1 | -1.92 | -1.6 |
| US DJ Industrial Average 30 | 17,737.4 | -170.5 | -0.95 | -0.5 |
| US Nasdaq Composite 100 | 4,704.1 | -32.1 | -0.68 | -0.7 |
| US S&P 500 | 2,044.8 | -17.3 | -0.84 | -0.7 |
| JP Nikkei 225 | 17,197.7 | 30.6 | 0.18 | -1.4 |
| HK Hang Seng Index 48 | 23,977.3 | 57.4 | 0.24 | 1.6 |
| AU S&P/ASX 200 | 5,422.7 | -42.9 | -0.78 | 0.2 |
| Commodities & FX | Mid/Close | Chg | % Chg | % YTD |
| Crude Oil, US Light Sweet ($/barrel) | 47.35 | -0.86 | -1.78 | -10.2 |
| Crude Oil, Brent ($/barrel) | 49.16 | 0.10 | 0.2 | -14.8 |
| Gold ($/oz) | 1229.75 | 6.35 | 0.52 | 3.4 |
| Silver ($/oz) | 16.62 | 0.10 | 0.59 | 5.3 |
| Platinum ($/oz) | 1233.50 | 10.00 | 0.82 | 2.0 |
| GBP/USD – US$ per £ | 1.517 | – | 0.07 | -2.7 |
| EUR/USD – US$ per € | 1.186 | – | 0.15 | -2.1 |
| GBP/EUR – € per £ | 1.279 | – | -0.07 | -0.6 |
Click graph to enlarge
See Live Macro Calendar for full data line-up, incl. consensus expectations
UK 100 Index called to open +18 points at 6504, after a frantic Friday where US Non-Farm payrolls came in better than expected and unemployment decreased to its lowest level (5.6%) since 2008, however wage slips fell and more people dropped out of the labour force. This led to the Dow Jones having an initial push upwards but declines ensued with a 170 drop. The Federal Reserve only in December cited the lack of evidence of rising wages, which means it may keep interest rates near zero for an extended period.
With Oil prices continuing to fall and a weakened dollar over the weekend, European bourses look set for a cautious open. Of note, Goldman Sachs this morning said in a note that oil needs to trade near $40 a barrel before OPEC will consider cutting output.
UK Pharmaceutical company Shire has been doing some January Sales shopping, although how much discount they received was negligible, as they tied up their biggest acquisition to date. They spent $5.2bn in acquiring US biotech rival NPS Pharmaceuticals to expand into rare diseases. After the failure of the Abbvie deal, Shire looks to be setting its own goals for 2015.
Asian markets were mixed following the choppy trading session seen on Friday. The Australian ASX the standout loser down almost 1% hurt by commodity based stocks. The Nikkei and Hang Seng both showed modest gains to erase early losses. Chinese stocks fell for the third day, its longest losing streak since November.
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
See Live Macro Calendar for full data line-up, incl. consensus expectations
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research